Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any age-related macular degeneration in which the cause of the disease is a mutation in the CFH gene.
Features include: Macular degeneration.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 1 | Macular degeneration |
Age of onset: later in life.
Biomarker and diagnostic research for age related macular degeneration 4 has been reported in the published literature.
No clinical trials have been registered for age related macular degeneration 4.
341 publications have been identified in PubMed for age related macular degeneration 4. Kisho has analyzed 116 by research type. Research spans Clinical Trial Publication (29%), Epidemiology / Natural History (26%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 34 | 29% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 7:57 AM UTC
Online Mendelian Inheritance in Man
Common questions about age related macular degeneration 4
Disease patterns and progression |
30 |
26% |
Laboratory research | 20 | 17% |
Research summaries | 15 | 13% |
Testing and diagnosis research | 8 | 7% |
New treatment approaches | 6 | 5% |
Other research | 2 | 2% |
Patient case studies | 1 | 1% |
Kilani A (2026). [PMID: 41524752](https://pubmed.ncbi.nlm.nih.gov/41524752/). *Graefes Arch Clin Exp Ophthalmol*. [Clinical Trial Publication]
Ke X (2026). [PMID: 42052823](https://pubmed.ncbi.nlm.nih.gov/42052823/). *Front Biosci (Landmark Ed)*. [Gene Therapy / Novel Therapeutics]
Ansari G (2026). [PMID: 42212881](https://pubmed.ncbi.nlm.nih.gov/42212881/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]
Allan KC (2026). [PMID: 41197713](https://pubmed.ncbi.nlm.nih.gov/41197713/). *Ophthalmol Retina*. [Epidemiology / Natural History]
Hua Z (2026). [PMID: 41503694](https://pubmed.ncbi.nlm.nih.gov/41503694/). *Curr Eye Res*. [Epidemiology / Natural History]
Korobelnik JF (2026). [PMID: 40876598](https://pubmed.ncbi.nlm.nih.gov/40876598/). *Ophthalmology*. [Clinical Trial Publication]
Yang CC (2026). [PMID: 41276957](https://pubmed.ncbi.nlm.nih.gov/41276957/). *J Chin Med Assoc*. [Clinical Trial Publication]
Castro-Fernández DC (2026). [PMID: 41643859](https://pubmed.ncbi.nlm.nih.gov/41643859/). *Surv Ophthalmol*. [Review / Meta-Analysis]
Pitcher JD 3rd (2026). [PMID: 41712218](https://pubmed.ncbi.nlm.nih.gov/41712218/). *JAMA Ophthalmol*. [Clinical Trial Publication]
Hong AT (2026). [PMID: 40803555](https://pubmed.ncbi.nlm.nih.gov/40803555/). *Ophthalmol Retina*. [Clinical Trial Publication]